Logo-bi
Editorial
Abolfazl Barzegari, Graciela Pavon-Djavid*
Bioimpacts. 2014;4(3): 111-112. doi: 10.15171/bi.2014.002
PMCID: PMC4204034     PMID: 25337462     Scopus ID: 84908154738    
PDF
XML
Cited By:
Editorial
Marisol Zuluaga*, Virginie Gueguen, Graciela Pavon-Djavid*, Didier Letourneur
Bioimpacts. 2017;7(1): 1-3. doi: 10.15171/bi.2017.01
PMCID: PMC5439384     PMID: 28546947     Scopus ID: 85019125691    
Original Research
Mostafa Akbarzadeh Khiavi ORCID, Azam Safary ORCID, Jaleh Barar ORCID, Hamed Farzi-Khajeh, Abolfazl Barzegari, Rahimeh Mousavi, Mohammad Hossein Somi* ORCID, Yadollah Omidi* ORCID
Bioimpacts. 2020;10(1): 27-36. doi: 10.15171/bi.2020.04
PMCID: PMC6977588     PMID: 31988854     Scopus ID: 85078959970    
The current study introduces an efficient ROS-responsive enzyme-based nanobiosystem and its biological impact in colon cancer therapy. Based on physicochemical properties, AuNPs-PEG-RNase A effectively induced apoptosis in SW-480 colon cancer cells and resulted in a significant reduction in cancer cell viability.


As a peer-reviewed international open-access journal, BioImpacts publishes articles on basic and translational aspects of pharmaceutical and biomedical sciences. 
Acceptance rate: 24% 
Publication fee: Free of charge